Your browser doesn't support javascript.
loading
Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review.
van Dyk, Madelé; Boylan, Chelsea; Michelet, Robin; Mc Laughlin, Anna M; Kichenadasse, Ganessan; May, Nikki; Ziesenitz, Victoria; Van Den Anker, Johannes N; Groenland, Stefanie L; Huitema, Alwin D R; Steeghs, Neeltje; Mikus, Gerd; Kloft, Charlotte; Tapp, Heather.
Afiliación
  • van Dyk M; Flinders Health and Medical Research Institute - Cancer, Flinders University, Adelaide, South Australia, Australia madele.vandyk@flinders.edu.au.
  • Boylan C; Flinders Health and Medical Research Institute - Cancer, Flinders University College of Medicine and Public Health, Bedford Park, South Australia, Australia.
  • Michelet R; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
  • Mc Laughlin AM; PharMetrX Graduate Research Training Program, Postdam/Berlin, UK.
  • Kichenadasse G; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
  • May N; Postdam/Berlin, PharMetrX Graduate Research Training Program, Postdam/Berlin, Germany.
  • Ziesenitz V; Flinders Health and Medical Research Institute - Cancer, Flinders University College of Medicine and Public Health, Bedford Park, South Australia, Australia.
  • Van Den Anker JN; Medical Oncology, Flinders Medical Centre, Bedford Park, South Australia, Australia.
  • Groenland SL; SA Health Library Service, Bedford Park, South Australia, Australia.
  • Huitema ADR; Pediatric Cardiology & Congenital Heart Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Steeghs N; Division of Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, Basel, Switzerland.
  • Mikus G; Division of Clinical Pharmacology, Children's National Hospital, Washington, District of Columbia, USA.
  • Kloft C; Antoni van Leeuwenhoek Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands.
  • Tapp H; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands.
BMJ Open ; 12(1): e053308, 2022 Jan 03.
Article en En | MEDLINE | ID: mdl-34980620

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia / Neoplasias Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia / Neoplasias Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article